Huntington National Bank »

C4 Therapeutics shares owned by Huntington National Bank

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.9k 107 45.96

More positions owned by Huntington National Bank

Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
JP MORGAN CHASE & Common Stock (JPM)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IVV)
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Ishares Exchange Traded (Principal) (IJH)
Ishares Exchange Traded (Principal) (IJR)
ELI LILLY & Common Stock (LLY)
Advanced Micro Devices Common Stock (AMD)
State Street Exchange Traded (Principal) (SPY)
Exxon Mobil Corp Common Stock (XOM)

View all positions for Huntington National Bank

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
BlackRock
Squadron Capital Management
Lynx1 Capital Management
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Goldman Sachs Group
Daniel D. Thurber
Two Sigma Investments
Soleus Capital Management
Silverarc Capital Management
Bank of America Corporation

View all funds holding C4 Therapeutics